Health ❯ Healthcare ❯ Pharmacology

Drug Development

Combination Therapy Clinical Trials Targeted Therapies Natural Compounds Baxdrostat BTK Inhibitors GLP-1 Receptor Agonists Therapeutics Ambroxol Cancer Therapies

3 ARTICLES

last mo.

CagriSema Combo Lowers Blood Sugar and Drives Bigger Weight Loss Than Semaglutide Alone

Additional analyses followed by regulatory review will determine whether the amylin-plus-GLP-1 approach becomes a new treatment option for people with type 2 diabetes.

5 ARTICLES

last mo.

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

6 ARTICLES

2mo ago

AI-Designed Miniproteins Target GPCRs in Nature Study

7 ARTICLES

2mo ago

FDA Approves Baxfendy, First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

4 ARTICLES

2mo ago

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

3 ARTICLES

5mo ago

Aloe Vera Compound Beta-Sitosterol Identified as Potential Alzheimer’s Drug Lead in Peer-Reviewed In Silico Study

3 ARTICLES

5mo ago

Repurposed Kidney Drug Triggers Egg Development in Small POI Trial, Science Study Reports

3 ARTICLES

6mo ago

Pooled Data Tie Early AE Management to Greater Zolbetuximab Benefit in Gastric/GEJ Cancer

9 ARTICLES

6mo ago

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

9 ARTICLES

7mo ago

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

8 ARTICLES

7mo ago

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

11 ARTICLES

7mo ago

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

3 ARTICLES

7mo ago

Pliant’s PLN-101095 With Keytruda Shows Early Responses in PD-1–Refractory Solid Tumors

6 ARTICLES

8mo ago

Roche Says Breast Cancer Pill Cuts Recurrence in Phase 3 Adjuvant Trial

3 ARTICLES

8mo ago

Bacterial RNA-Repair System Identified as New Target to Boost Common Antibiotics

Drug Development

CagriSema Combo Lowers Blood Sugar and Drives Bigger Weight Loss Than Semaglutide Alone

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

AI-Designed Miniproteins Target GPCRs in Nature Study

FDA Approves Baxfendy, First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension

Lithium Chloride Rewires Alzheimer’s-Linked Pathways in Cell Study

Major Review Says New Alzheimer’s Antibodies Offer No Meaningful Benefit

Acoramidis Shows Durable Survival Benefit in ATTR-CM Through 54 Months

Mavacamten Cuts Heart Outflow Obstruction in Teens in First Randomized Trial

NEJM Publication Confirms Phase 3 Win for Brepocitinib in Dermatomyositis

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Never miss stories about

Drug Development

Aloe Vera Compound Beta-Sitosterol Identified as Potential Alzheimer’s Drug Lead in Peer-Reviewed In Silico Study

Repurposed Kidney Drug Triggers Egg Development in Small POI Trial, Science Study Reports

Pooled Data Tie Early AE Management to Greater Zolbetuximab Benefit in Gastric/GEJ Cancer

FDA Approves Vanda’s Nereus, First New Motion Sickness Treatment in Over 40 Years

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

Pirtobrutinib Extends First-Line PFS vs BR and Shows Higher Response Rates Than Ibrutinib in CLL/SLL

Pliant’s PLN-101095 With Keytruda Shows Early Responses in PD-1–Refractory Solid Tumors

Roche Says Breast Cancer Pill Cuts Recurrence in Phase 3 Adjuvant Trial

Bacterial RNA-Repair System Identified as New Target to Boost Common Antibiotics

Never miss stories about

Drug Development